【レポートの概要（一部）】
Table of Content
Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Injectable drug delivery market – Industry Summary and Key Buying Criteria, 2013 – 2024
Chapter 3. Injectable Drug DeliveryIndustry Outlook
3.1. Market segmentation
3.2. Market size and growth prospects, 2013 – 2024
3.3. Injectable drug delivery: Market dynamics
3.3.1. Market driver analysis
3.3.1.1. Escalation in demand for self- injection devices
3.3.1.2. Increase in number of chronic diseases
3.3.1.3. Innovative technological progress
3.3.1.4. Development of the biologics market
3.3.2. Market restraint analysis
3.3.2.1. Needle stick injuries and infections
3.3.2.2. Preference over other drug delivery systems
3.3.2.3. Sterility of injectables
3.4. Injectable drug delivery market: Industry trend analysis
3.5. Injectable drug delivery market – PESTEL Analysis
3.6. Injectable drug delivery Industry analysis – Porter’s Five Forces Model
3.7. Injectable drug delivery: Company Market Share Analysis (%), 2015
3.8. Key opportunities prioritized
Chapter 4. Injectable Drug Delivery Product Type Outlook
4.1. Injectable Drug Delivery Revenue Share (%) Analysis, by Product Outlook, 2016 & 2024
4.2. By Devices
4.2.1. Self-injection devices
4.2.1.1. Self-injection devices market revenue, by region, 2013 to 2024 (USD Million)
4.2.2. Conventional devices
4.2.2.1. Conventional drug delivery market revenue, by region, 2013 to 2024 (USD Million)
4.3. By Formulations
4.3.1. Conventional drug delivery
4.3.1.1. Conventional drug delivery market revenue, by region, 2013 to 2024 (USD Million)
4.3.2. Novel drug delivery
4.3.2.1. Novel drug delivery market revenue, by region, 2013 to 2024 (USD Million)
4.4. Others
4.4.1. Others market revenue, by region, 2013 to 2024 (USD Million)
Chapter 5. Injectable Drug Delivery Therapeutic Use Outlook
5.1. Injectable Drug Delivery Revenue Share (%) Analysis, by Therapeutic Use Outlook, 2016& 2024
5.2. Autoimmune disorders
5.2.1. Autoimmune disorders injectable drug delivery market, by region, 2013 to 2024 (USD Million)
5.3. Hormonal disorders
5.3.1. Hormonal disorders injectable drug delivery market, by region, 2013 to 2024 (USD Million)
5.4. Oncology
5.4.1. Oncology injectable drug delivery market, by region, 2013 to 2024 (USD Million)
5.5. Others
5.5.1. Others drug injectable drug delivery market, by region, 2013 to 2024 (USD Million)
Chapter 6. Injectable Drug Delivery End-User Application Outlook
6.1. Injectable Drug Delivery Revenue Share (%) Analysis, by End-User Application, 2016& 2024
6.2. Hospital
6.2.1. Hospital market revenue, by region, 2013 to 2024 (USD Million)
6.3. Homecare Settings
6.3.1. Homecare settings market revenue, by region, 2013 to 2024 (USD Million)
6.4. Others
6.4.1. Others market revenue, by region, 2013 to 2024 (USD Million)
Chapter 7. Injectable Drug Delivery Regional Outlook
7.1. Injectable drug delivery Market Share (%) Analysis, by Region, 2013&2024
7.2. North America
7.2.1. U.S.
7.2.1.1. U.S. injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.2.1.2. U.S injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.2.1.3. U.S. injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.2.1.4. U.S. injectable drug deliverymarket, by end-user application, 2013 – 2024 (USD Million)
7.2.2. Canada
7.2.2.1. Canada injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.2.2.2. Canada injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.2.2.3. Canada injectable drug delivery market, by therapeutic use,2013 – 2024 (USD Million)
7.2.2.4.Canada injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.3. Europe
7.3.1. Germany
7.3.1.1. Germany injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.3.1.2. Germany injectable drug delivery market by formulation, 2013 – 2024 (USD Million)
7.3.1.3. Germany injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.3.1.4. Germany injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.3.2. UK
7.3.2.1. UK injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.3.2.2. UK injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.3.2.3. UK injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.3.2.4. UK injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.4. Asia-Pacific
7.4.1. China
7.4.1.1. China injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.4.1.2. China injectable drug delivery market by formulation, 2013 – 2024 (USD Million)
7.4.1.3. China injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.4.1.4. China injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.4.2. India
7.4.2.1. India injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.4.2.2. India injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.4.2.3. India injectable drug delivery market, by therapeutic use 2013 – 2024 (USD Million)
7.4.2.4. India injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.5. MEA
7.5.1. South Africa
7.5.1.1. South Africa injectable drug delivery market, by device, 2012 – 2024 (USD Million)
7.5.1.2. South Africa injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.5.1.3. South Africa injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.5.1.4. South Africa injectable drug deliverymarket, by end-user application, 2013 – 2024 (USD Million)
7.5.2. Saudi Arabia
7.5.2.1. Saudi Arabia injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.5.2.2. Saudi Arabia injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.5.2.3. Saudi Arabia injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.5.2.4. Saudi Arabia injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Brazil injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.6.1.2. Brazil injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.6.1.3. Brazil injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.6.1.4. Brazil injectable drug deliverymarket, by end-user application, 2013 – 2024 (USD Million)
7.6.2. Mexico
7.6.2.1. Mexico injectable drug delivery market, by device,2013 – 2024 (USD Million)
7.6.2.2. Mexico injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.6.2.3. Mexico injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.6.2.4. Mexico injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
Chapter 8. Competitive Landscape
8.1. Pfizer, Inc.
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. Baxter International, Inc.
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Schott AG
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Becton, Dickinson and Company
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. ELI Lily and Company
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. Alkermes PLC
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. Terumo Corporation
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8 Elcam Medical
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9 Unilife Corporation
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
【レポート販売概要】
■ タイトル：注射薬物送達の世界市場の収益分析：機器別（自己注射機器、従来の機器）、処方別（従来型薬物送達、新規型薬物送達）、治療使用方法別（自己免疫疾患、ホルモン障害、腫瘍学）、エンドユーザー用途別（病院、ホームケア施設、研究機関、臨床検査室）、地域別（アメリカ、カナダ、ドイツ、英国、中国、インド、南アフリカ、サウジアラビア、ブラジル、メキシコ）、セグメント予測、2013-2024■ 英文：Injectable Drug Delivery Market Analysis, By Device Type (Self-injection Devices, Conventional Devices), By Formulation (Conventional Drug Delivery, Novel Drug Delivery), By Therapeutic Use (Autoimmune Disorders, Hormonal Disorders, Oncology), By End-user Application (Hospitals, Homecare Settings, Research Institutes, Clinical Laboratories), By Region (U.S, Canada, Germany, U.K, China, India, South Africa, Saudi Arabia, Brazil, Mexico) And Segment Forecasts From 2013 to 2024
■ 発行日：2016年8月11日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707435
■ 調査対象地域：グローバル
- 寒冷式疼痛治療の世界市場予測（～2021年）：OTC医薬品、医療機器、処方薬Cold pain therapy is among the most commonly adopted methods for the temporary management of pain and inflammation, sprains, strains, bumps, bruises, and arthritis. Pharmaceuticals used for cold pain therapy have menthol as their active ingredient (with menthol content of 1% and above), whereas medical devices have ice or cold water as their key component. Menthol in topical analgesics acts as a c …
- ナトリウム（Sodium）の市場別医療検査数および販売予測This new report from Venture Planning Group provides analysis of Sodium testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralize …
- 自動車用雨滴感知式ワイパーの世界市場2017-2021About Automotive Rain Sensing Wiper SystemA wiper system is an electromechanical component placed on the windshield of automobiles. It is used to enhance the visibility of the windshield by wiping off unwanted sand, dust, and water particles caused by harsh weather conditions such as dust storms, rain, and snow.Rain sensors are used in wiper units of vehicles for automatic wiping. Rain sensing win …
- 移動体通信事業者（MNO）のM2M戦略（Mobile Network Operator Machine-to-Machine (M2M) Strategies）Machine to Machine (M2M) is unleashing a wave of new possibilities for data gathering, predictive analytics and automation. M2M can be employed in various mundane yet important tasks in virtually every industry/segment including healthcare, telematics, asset management, surveillance, power grid, connected home, connected car and much more. M2M services are a key part of every successful enterprise …
- 世界のアナログIC市場動向（2014～2018）TechNavio's analysts forecast the Global Analog IC market to grow at a CAGR of 4.79 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need for power management in electronic products. The Global Analog IC market has also been witnessing the emerging applications of analog ICs in LED lighting systems. However, the demand and supply imbalance of anal …
- 中東・アフリカにおける2G/3G/4G無線通信加入者、周波数ライセンス、保有・インフラ契約動向（2014 – 2020）Covering over 70 countries and 270 wireless carriers in the Middle East & Africa region, the “Middle East & Africa 2G, 3G & 4G Wireless Subscriptions, Spectrum Licensing, Ownership & Infrastructure Contracts Database: 2014 – 2020” database tracks mobile network subscriptions, penetration, spectrum licensing, mobile infrastructure contracts and network ownership data. The database is delivered as a …
- SwitzerlandのCalcium Carbonate市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Switzerland and its perspectives on the global market for Calcium carbonate. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on Calcium carbonate export/import operations in Switzerland. The 2002-2012 period is co …
- ウェハレベルパッケージング装置の世界市場2015-2019About Wafer-level Packaging Equipment ICs are very delicate in nature, therefore, prone to contamination that can cause malfunctioning. To eliminate such issues, silicon chips or ICs are protected by using packaging materials. Wafer level packaging is one such type of packaging, which involves the packaging of individual ICs using best fit packaging processes conducted at wafer level manufacturing …
- イソブテンの世界市場の規模と予測：製品別（メチルtert-ブチルエーテル（MTBE）、エチルtert-ブチルエーテル（ETBE））、用途別（自動車、航空宇宙、酸化防止剤、医薬品）、セグメント予測The global isobutene market is expected to reach USD 30.71 billion by 2024, according to a new report by Grand View Research, Inc. Regulatory policies aimed at carcinogenicity of petrochemicals to have a huge impact on industry dynamics and product development sources. The primary market driver is the growing demand for rubber from the automotive industry. It used primarily used as a precursor to …
- 世界の自動車用サスペンション・システム市場（2014-2018）About Automotive Suspension Systems An automotive suspension system is an assembly of springs, shock absorbers, and linkages that connects a vehicle to its wheels. Suspension systems help a driver maintain control over the vehicle on rough terrains or at the time of sudden halts on a road. Air suspension systems and electromagnetic advanced suspension systems are gaining popularity among end-users …
- クラウド分析ソリューションの世界市場：クラウドBIツール、データウェアハウス、CEP、EIM、EPM、GGR、分析ソリューションToday business organizations are operational across various verticals which include Banking, Financial Services, and Insurance (BFSI), retail and consumer goods, telecommunication, health care and life sciences, media and entertainment, government, business and consulting services, research and education, energy, and manufacturing. There are huge amounts of unstructured data getting generated duri …
- 世界主要国のコクサッキーウイルス検査（医療機器）市場The report presents a detailed analysis of the Coxsackievirus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Coxsackievirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals & …
- 世界の波長分割マルチプレクサ市場2015The Global Wavelength Division Multiplexer Industry Report 2015 is a professional and in-depth study on the current state of the Wavelength Division Multiplexer industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Wavelength Division Multiplexer market analysis is provided for the international markets …
- ネットワーク・トランスフォーメーションの世界市場予測（～2022年）“The network transformation market is expected to grow at a Compound Annual Growth Rate (CAGR) of 61.9% during the forecast period”The global network transformation market size is expected to grow from USD 6.01 billion in 2017 to USD 66.86 billion by 2022, at a CAGR of 61.9% during the forecast period. There is an increase in the adoption of the BYOD and remote workplace management trends. Enterpr …
- 有毛細胞白血病治療薬の世界市場：化学療法、標的療法Global Hairy Cell Leukemia Therapeutics Market: About this market Hairy cell leukemia is a rare, slow-growing subtype of leukemia, which accounts for about 2% of the total cases of leukemia. Technavio’s hairy cell leukemia therapeutics analysis considers sales from both chemotherapies and targeted therapy. Our analysis also considers the sales of hairy cell leukemia therapeutics in North America, …
